Hemorheological and hemodynamical effects of fish oil (Ameu) in patients with ischemic heart disease and hyperlipoproteinemia

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Omega-3-fatty acids (n-3-FA) have various positive hemorheological effects in different clinical conditions. Ten male patients (mean age: 50 years) with ischemic heart disease and hyperlipoproteinemia were studied. They were treated by 10 capsules of Ameu (Omega Pharma, Berlin, Germany; 0.5 g salmon oil with 33% of n-3-FA) daily for two months. Besides routine laboratory parameters, hemorheological measurements (whole blood, plasma and serum viscosity) and exercise stress test with noninvasive hemodynamic control at baseline and after two months of treatment were carried out. Significant decrease (p <0.01) of triglycerides (58%) was found. Cholesterol and plasma viscosity showed only a moderate decrease. Whole blood viscosity, exercise capacity and the measured hemodynamic parameters improved significantly (p <0.05 or better). Our results show that this preparation can be useful in clinical practice because it has a beneficial effect on plasma lipids and on hemorheological and hemodynamic parameters.

Original languageEnglish
Pages (from-to)867-875
Number of pages9
JournalClinical Hemorheology
Volume15
Issue number6
Publication statusPublished - 1995

Fingerprint

Hyperlipoproteinemias
Fish Oils
Myocardial Ischemia
Hemodynamics
Exercise Test
Viscosity
Blood Viscosity
Omega-3 Fatty Acids
Berlin
Capsules
Germany
Triglycerides
Cholesterol
Exercise
Lipids
Serum
Therapeutics

Keywords

  • blood rheology
  • cardiac index
  • hyperlipoproteinemia
  • ischemic heart disease
  • Omega-3-fatty acids

ASJC Scopus subject areas

  • Hematology
  • Physiology

Cite this

@article{d2b5151bdf894da88890e98e2c056c8a,
title = "Hemorheological and hemodynamical effects of fish oil (Ameu) in patients with ischemic heart disease and hyperlipoproteinemia",
abstract = "Omega-3-fatty acids (n-3-FA) have various positive hemorheological effects in different clinical conditions. Ten male patients (mean age: 50 years) with ischemic heart disease and hyperlipoproteinemia were studied. They were treated by 10 capsules of Ameu (Omega Pharma, Berlin, Germany; 0.5 g salmon oil with 33{\%} of n-3-FA) daily for two months. Besides routine laboratory parameters, hemorheological measurements (whole blood, plasma and serum viscosity) and exercise stress test with noninvasive hemodynamic control at baseline and after two months of treatment were carried out. Significant decrease (p <0.01) of triglycerides (58{\%}) was found. Cholesterol and plasma viscosity showed only a moderate decrease. Whole blood viscosity, exercise capacity and the measured hemodynamic parameters improved significantly (p <0.05 or better). Our results show that this preparation can be useful in clinical practice because it has a beneficial effect on plasma lipids and on hemorheological and hemodynamic parameters.",
keywords = "blood rheology, cardiac index, hyperlipoproteinemia, ischemic heart disease, Omega-3-fatty acids",
author = "K. T{\'o}th and E. Ernst and T. Habon and I. Horv{\'a}th and I. Juricskay and G. M{\'o}zsik",
year = "1995",
language = "English",
volume = "15",
pages = "867--875",
journal = "Clinical Hemorheology and Microcirculation",
issn = "1386-0291",
publisher = "IOS Press",
number = "6",

}

TY - JOUR

T1 - Hemorheological and hemodynamical effects of fish oil (Ameu) in patients with ischemic heart disease and hyperlipoproteinemia

AU - Tóth, K.

AU - Ernst, E.

AU - Habon, T.

AU - Horváth, I.

AU - Juricskay, I.

AU - Mózsik, G.

PY - 1995

Y1 - 1995

N2 - Omega-3-fatty acids (n-3-FA) have various positive hemorheological effects in different clinical conditions. Ten male patients (mean age: 50 years) with ischemic heart disease and hyperlipoproteinemia were studied. They were treated by 10 capsules of Ameu (Omega Pharma, Berlin, Germany; 0.5 g salmon oil with 33% of n-3-FA) daily for two months. Besides routine laboratory parameters, hemorheological measurements (whole blood, plasma and serum viscosity) and exercise stress test with noninvasive hemodynamic control at baseline and after two months of treatment were carried out. Significant decrease (p <0.01) of triglycerides (58%) was found. Cholesterol and plasma viscosity showed only a moderate decrease. Whole blood viscosity, exercise capacity and the measured hemodynamic parameters improved significantly (p <0.05 or better). Our results show that this preparation can be useful in clinical practice because it has a beneficial effect on plasma lipids and on hemorheological and hemodynamic parameters.

AB - Omega-3-fatty acids (n-3-FA) have various positive hemorheological effects in different clinical conditions. Ten male patients (mean age: 50 years) with ischemic heart disease and hyperlipoproteinemia were studied. They were treated by 10 capsules of Ameu (Omega Pharma, Berlin, Germany; 0.5 g salmon oil with 33% of n-3-FA) daily for two months. Besides routine laboratory parameters, hemorheological measurements (whole blood, plasma and serum viscosity) and exercise stress test with noninvasive hemodynamic control at baseline and after two months of treatment were carried out. Significant decrease (p <0.01) of triglycerides (58%) was found. Cholesterol and plasma viscosity showed only a moderate decrease. Whole blood viscosity, exercise capacity and the measured hemodynamic parameters improved significantly (p <0.05 or better). Our results show that this preparation can be useful in clinical practice because it has a beneficial effect on plasma lipids and on hemorheological and hemodynamic parameters.

KW - blood rheology

KW - cardiac index

KW - hyperlipoproteinemia

KW - ischemic heart disease

KW - Omega-3-fatty acids

UR - http://www.scopus.com/inward/record.url?scp=0029584639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029584639&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 867

EP - 875

JO - Clinical Hemorheology and Microcirculation

JF - Clinical Hemorheology and Microcirculation

SN - 1386-0291

IS - 6

ER -